Home » Topics » Regulatory » Patents

Patents
RSS

COX-2 inhibitors from Merck Frosst

June 28, 1996

Merck & Co. claims process for synthesizing HIV protease inhibitors

June 28, 1996

Antifungal agents revealed by Merck & Co.

June 28, 1996

Antibacterial agents revealed by Wakunaga

June 28, 1996

Pharmacia & Upjohn reveal antimicrobial phenyloxazolidinones

June 28, 1996

Fujisawa discloses bradykinin antagonists

June 28, 1996

Teikoku Hormone reveals novel octadecapeptide

June 21, 1996

Lilly discloses insulin analogues

June 21, 1996

Anakinra claimed for pancreatitis

June 21, 1996

Genelabs Technologies describes hepatitis E virus

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...